Midas Pharmasec Ltd Stock Analysis

BSE: 530257 | NSE: | Trading | Small Cap

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Midas Pharmasec

M-Cap below 100cr DeciZen not available

Midas Pharmasec Price Chart

P/E Ratio ( SA) :
Market Cap :
28.6 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Midas Pharmasec Ltd. a good quality company?

Data is not available for this company.

2. Is Midas Pharmasec Ltd. undervalued or overvalued?

No data found

3. Is Midas Pharmasec Ltd. a good buy now?

No data found

10 Year X-Ray of Midas Pharmasec:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

ROCE % -0.7%-2.6%-2.4%-1.6%-1.5%-0.9%-36.9%-15%-21.7%2%-

Growth Parameters

Growth Parameters Colour Code Guide

YoY Gr. Rt. %--80.5%239.1%-91%-57.1%633.3%13.6%-64%44.4%84.6%-
Adj EPS -0.1-0.2-0.2-0.1-0.1-0.1-2.6-1.6-
BVPS (₹)
Adj Net Profit 0-0.1-0.1-0.100-0.9-0.3-1.10.20
Cash Flow from Ops. 000.3-
Debt/CF from Ops. 0000000000-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -16.2%51.6%-1.4%84.6%
BVPS 0.3217.82.2
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % -0.7-2.7-2.4-1.6-1.5-0.9-36.9-15-21.724.4
Op. Profit Mgn % -1.3-32.1-8.3-80.6-199.1-16.7-345.3-294.7-914.3-41.30
Net Profit Mgn % -1.8-34-8.9-67.5-156.6-11-342-295.5-908.171.90
Debt to Equity 0000000000-
Working Cap Days 9194,4481,24314,22136,1004,4573,2036,8147,0724,1400
Cash Conv. Cycle 7253,5591,02110,19621,7032,6732,2035,6252,3011790

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Midas Pharmasec Ltd.

Standalone Consolidated
TTM EPS (₹) 0.4 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 9.3 -
Reserves (₹ Cr.) -1 -
P/BV 3.07 -
PE 71.38 -
From the Market
52 Week Low / High (₹) 26.65 / 29.45
All Time Low / High (₹) 0.85 / 31.80
Market Cap (₹ Cr.) 28.6
Equity (₹ Cr.) 10
Face Value (₹) 10
Industry PE 47.9

Management X-Ray of Midas Pharmasec :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Midas Pharmasec

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Midas Pharmasec Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Midas Pharmasec on 01-Jan-1970 05:30 is : 0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Midas Pharmasec stood at ₹ 28.55.
The latest PE ratio of Midas Pharmasec as of 01-Jan-1970 05:30 is 71.38.
The latest PB ratio of Midas Pharmasec as of 01-Jan-1970 05:30 is 3.07
The 52-week high of Midas Pharmasec is ₹ 29.45 and the 52-week low is ₹ 26.65.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Midas Pharmasec is ₹ 0.00 ( Cr.) .

About Midas Pharmasec Ltd

Midas Pharmasec was incorporated in 1994. The registered office of the company is located at 20/A Sagar Bhuvan, 3rd Floor, 98, Lohar Chawl, Mumbai-400002.

Business area of the company

The company has trading activities in pharmaceuticals and investments in the capital markets. The company gets income from its trading activities and from the sale of shares and securities, dividend and interest.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now